Abstract Inwardly rectifying K + (Kir) channels are important contributors to the resting membrane potential and regulate cellular excitability. The activity of Kir channels depends critically on the phospholipid PIP 2 . Several modulators of the activity of Kir channels alter the apparent affinity of the channel to PIP 2 . Channels with high apparent affinity to PIP 2 may not respond to a given modulator, but mutations that decrease such affinity can render the channel susceptible to modulation. Here, we identify a known inhibitor of the swelling-activated Cl − current, DCPIB, as an effective inhibitor of a number of Kir channels both in native cardiac cells and in heterologous expression systems. We show that the apparent affinity to PIP 2 determines whether DCPIB will serve as an efficient blocker of Kir channels. These effects are consistent with a model in which DCPIB competes with PIP 2 for a common binding site.
Introduction
Inwardly rectifying potassium channels (Kir) have been found in a wide variety of tissues and play important roles in numerous physiological and pathological processes [6] . Seven subfamilies of Kir channels have been identified. Besides intracellular magnesium and polyamines that cause various degrees of inward rectification, phosphatidylinositol 4,5-bisphosphate (PIP 2 ) has been found to act as a common regulator of the activity of all Kir channels [9, 10, 30, 33] .
Recent identification of the structures of several Kir channels has allowed a more detailed understanding of the structural basis of PIP 2 sensitivity. Based on available structures, it has been proposed that the positively charged residues critical for PIP 2 interaction form a pocket involving both the N-and C-termini of Kir channels [9, 10] . PIP 2 is essential for the activities of all Kir channels and their regulators, including Gβγ [19, 29] , intracellular Na + [7, 25, 28, 29] , phosphorylation [13, 15, 23] , and pH [1, 5, 21, 22] , all of which modulate channel activity by altering channel-PIP 2 interactions [7, 9, 10, 19, 25, 29, 30, 33] .
Among Kir channels, the cardiac K ACh and K ATP channels, whose activity is highly modulated by a number of intracellular molecules, show some of the lowest apparent affinities and stereospecificities to phosphoinositides [24] . In contrast, channels that exhibit high apparent affinities and stereospecificities for PIP 2 are ones that are least affected by intracellular modulators [24] .
DCPIB is a sensitive and specific blocker of the swellingactivated chloride current (I Cl,swell ) [2] . Previous studies showed that DCPIB has no effect on Ca 2+ channels, Na + channels, the CLC Cl − channel family, human cystic fibrosis transmembrane conductance regulator (hCFTR), and multiple K + channels including I Ks , I Kr , I K1 , I Kur , and I to1 [2] . Recently, DCPIB was found to be an activator of TREK potassium channels in cultured astrocytes [17] . Here, we show that DCPIB blocks members of the Kir channel family, and its inhibitory effect is dependent on the strength of channel-PIP 2 interaction. DCPIB (10 μM) blocked I KACh in native myocytes and reversed ACh-induced action potential duration (APD) shortening. DCPIB inhibited the currents elicited by Kir3.1/Kir3.4, Kir3.4, and Kir6.2, which are Kir channels with relatively weak affinity for PIP 2 . On the other hand, Kir2.1 and Kir2.3, which exhibit stronger channel-PIP 2 interaction, were insensitive to DCPIB. Strengthening channel-PIP 2 interaction in Kir3.4 by mutating I229 to Leu and D216 to Asn reduced the sensitivity of Kir3.4 to DCPIB, while mutating R312 in Kir2.1 to Gln weakened channel-PIP 2 interaction and rendered the mutant channel sensitive to DCPIB.
Methods

Molecular biology and channel expression in Xenopus oocytes
Point mutations were generated using Pfu-based the QuickChange site-directed mutagenesis kit (Stratagene). The cDNA was linearized and transcribed into cRNA using the Message Machine kit (Ambion). Oocytes were isolated and microinjected with cRNA of different Kir channels. The amount of cRNA was adjusted based on the level of the expressed currents. All oocytes were maintained at 17°C.
Atrial myocyte isolation
Atrial myocytes were freshly isolated from adult New Zealand White rabbits (2.8-3.1 kg) of either gender. Hearts were excised, immediately mounted on a Langendorff column, and perfused for 5 min with Tyrode solutions containing (in mM): 130 NaCl, At the end of the experiment, barium chloride (2 mM) was used to block potassium currents and obtain measurements of the remaining leak current.
Macropatch recording (Xenopus oocytes) Macropatch recordings were performed 2-6 days after injection. Inside-out patches were excised and currents were recorded using an Axopatch 200A patch-clamp amplifier and pClamp8 data acquisition software (Molecular Devices). Electrodes were made using Sutter P-97 microelectrode puller (Sutter Instrument) and the tip diameters were 10-25 μm. The bath and pipette solutions of ND96K + EGTA contained (in mM): 96 KCl, 1 MgCl2, 5 EGTA, and 10 HEPES, pH 7.4. Dose-response curves for current reactivation were constructed by adding different concentrations of diC8-PIP 2 (Avanti Polar Lipids) to the bath solution. Currents were recorded at a holding membrane potential of −80 mV.
Whole-cell patch clamp and electrophysiological recordings (atrial myocytes) Pipettes were pulled using a P-97 micropipette puller (Sutter Instrument) and then fire polished. The final pipette tip diameter was 2-3 μm, and resistance was 2-4 MΩ. Junction potentials were corrected, and a 3-M KCl-agar bridge served as the ground electrode. Freshly isolated atrial myocytes were dispersed over a glass-bottomed cell chamber (∼0.3 ml) and extracellular solution was superfused at a rate of 2-3 ml/min. Typical seal resistances were 5-10 GΩ. Myocytes were dialyzed for at least 5 min before data were collected. After obtaining the whole-cell configuration, successive 250 ms long steps were applied from −50 mV or −80 mV to test potentials between −100 and +40 mV in +10 mV increments, and current-voltage (I-V) relationships were plotted from quasi steady-state currents. Currents were recorded with an Axoclamp 200B and Digidata 1322A under pClamp 9 (MDS Analytical Technology) and digitized (5 kHz) after low-pass filtering (Bessel, 2 kHz). The high-K/low-Cl extracellular solution contained (in mM): 90 NaMeSO 3 , 30 KMeSO 3 , 20 KCl, 0.5 CaCl 2 , 1.0 MgCl 2 , 10 HEPES, pH 7.4. The pipette solution contained (in mM): K-aspartate 110, KCl 20, NaCl 10, MgCl 2 1.0, Na 2 -ATP 2.0, EGTA 2.0, Na 2 -GTP 0.01, HEPES 10, pH 7.4. To obtain I KACh , ACh (10 μM) was added into the bath solution and 100 nM tertiapin-Q (Tocris) was used to block I KACh currents. To examine the effect of GTPγS, GTPγS (100 μM) was added to the pipette solution, and the myocytes were dialyzed for at least 10 min before data were collected. Currents were normalized for cell size by dividing current amplitude (pA) by membrane capacitance (pF) to obtain current density.
For action potential recordings, myocytes were stimulated at 1 Hz with 1-ms pulses, and the membrane potential was digitized (10 KHz, Bessel filtered at 2 KHz). At least 30 action potentials were recorded to verify that the APD was stable, and the last ten action potentials were averaged. APD at 50 and 90 % repolarization (APD50, APD90) were calculated from averaged records.
Data analysis
All electrophysiology data were analyzed using the Clampfit 8 and Sigmaplot software. Data are reported as mean ± SEM. Statistical significance, taken as P < 0.05, was evaluated by Student's t test or one-way repeated measures ANOVA and the Holm-Sidak method (SigmaStat 3.11).
Molecular docking
Docking was performed using AutoDock Vina [31] . The DCPIB molecular structure [IUPHAR database: [27] ] was docked to both conformations of the Kir3.1 chimera structure (PDB code: 2QKS) [18] . Missing sidechains and residues in the channel structures were built using the loop-modeling routine of Modeller [26] . All nine rotatable bonds on DCPIB were allowed to rotate, and global docking was performed within a 120 × 120 × 135 angstrom box encompassing the entire channel structure at an exhaustiveness level of 2000. Three independent docking runs using different random seeds were performed for each conformation of the channel, and the top 5 binding modes predicted by each run were analyzed. Docking to the "open" conformation of the Kir3.1 chimera structure consistently predicted binding modes within the same channel pocket as the known PIP2 binding site and achieved predicted binding affinities as great as −9.4 kcal/mol. Docking results for the "closed" conformation of the channel structure produced variable results with predicted binding modes in the transmembrane, pore, and intracellular regions of the channel and binding affinities as great as −8.9 kcal/mol. The final selected model thus reflects the highest predicted affinity structure from docking to the "open" conformation of the channel. Contact residues of the channel were defined as those having at least one atom within 4 Å of the ligand structure.
Results
DCPIB inhibits I KACh in adult atrial myocytes
Firstly, we examined the effect of DCPIB on I KACh in freshly dissociated atrial myocytes. As shown in Fig. 1a -c, ACh elicited an inwardly rectifying current with an amplitude of −7.71 ± 1.36 pA/pF at −80 mV (n = 5, P < 0.001). Addition of DCPIB (10 μM; 10 min) in the presence of ACh inhibited 112 ± 13 % of the ACh-induced current (n = 5, P < 0.001). The current after the addition of DCPIB was not significantly different than the basal current (n = 5, P = 0.84). Figure 1d , e shows that ACh shortened the APD 50 and APD 90 by 25 ± 5 and 37 ± 4 ms, respectively (n = 6, P < 0.05 for both), and the APD shortening effect of ACh was completely reversed by DCPIB (10 μM, 10 min).
Intracellular PIP 2 abrogates the inhibitory effect of DCPIB on I KACh in adult atrial myocytes
Since the activity of I KACh is dependent on PIP 2 , next we studied the effect of intracellularly applied DiC8 PIP 2 (200 μM) on the inhibitory effect of DCPIB. As Fig. 2a, b show, with 200 μM DiC8 PIP 2 in the pipette, DCPIB (10 μM) failed to inhibit I KACh currents (n = 4, P = 0.22), while tertiapin-Q (100 nM) completely blocked the ACh-induced currents of the same cell (n = 4, P < 0.001).
DCPIB inhibits Kir3.1/Kir3.4 heteromeric channels expressed in oocytes
In order to pursue the molecular determinants of the inhibitory action of DCPIB on K ACh currents, we expressed Kir3.1/ Kir3.4 in Xenopus oocytes. Figure 3a , c-f demonstrate that DCPIB suppressed the basal whole-cell Kir3.1/Kir3.4 currents in a dose-dependent manner with an EC 50 = 22.1 ± 3.3 μM. The inhibition was not voltage dependent. At 200 μM, DCPIB inhibited 89 ± 3 % of the Kir3.1/Kir 3.4 current at −100 mV (n = 18, P < 0.001). Application of AChinduced additional current, when M2 receptors were coexpressed with Kir3.1/Kir3.4, and DCPIB also dosedependently inhibited the Kir3.1/Kir3.4 current in the continuous presence of ACh (n = 11, P < 0.001, Fig. 3b, g ). Because the TEVC recordings of Xenopus oocytes may not be ideal for a blocker that might work inside the cells, we performed inside-out macropatch recordings. As shown in Fig. 3h , DCPIB in the bath solution inhibited Kir3.1/Kir3.4 heteromeric currents in a dose-dependent manner with an EC 50 = 3.3 ± 0.6 μM. The lower EC 50 obtained when DCPIB was applied at the cytosolic surface of the channel further supports the interpretation that its site of action is intracellular.
The inhibitory effect of DCPIB is determined by channel-PIP 2 interactions
Since not only Kir3 but all Kir family members are regulated by PIP 2 , we investigated the effect of DCIPB on other cardiac Kir channels. Figure 4a shows that DCPIB (200 μM) inhibited whole-cell currents from oocytes expressing Kir3.4 (n = 7, P < 0 . 0 0 1 ) , K i r 6 . 2 / S U R ( n = 7, P < 0 . 0 0 1 ) , a n d Kir6.2Delta36 (n = 5, P < 0.001). However, DCPIB had minimal effect on Kir2.1 (n = 8, P = 0.97) and Kir2.3 currents (n = 7, P = 0.85). Figure 4b shows the dose-response curve for reactivation of Kir channels by DiC8 PIP 2 respectively), were largely inhibited by DCPIB. Similar results were obtained with the non-cardiac Kir7.1 channel that exhibits a low EC 50 for PIP 2 (45.5 ± 2.3 μM) and a high fractional block by 200 μM DCPIB (>80 %). In order to further investigate the relationship between the channel apparent affinity for PIP 2 and DCPIB blockade, we modulated channel-PIP 2 interactions by mutating critical residues. As shown in Fig. 5a , b, mutation of R312 of Kir2.1 to Gln not only weakened channel-PIP 2 interactions, as indicated by the higher EC 50 for DiC8 PIP 2 activation (3.1 ± 0.4 vs. 52.2 ± 2.3 μM) but also rendered the channel sensitive to DCPIB (n = 6, P < 0.001). Compared to Kir2.1(R312Q), the Kir2.1(L222I) mutant that had a higher apparent affinity for PIP 2 (EC 50 = 18.8 ± 4.5 μM) remained insensitive to DCPIB (n = 7, P = 0.52). Similarly, increasing the Kir3.4 channel's apparent affinity for PIP 2 by mutating I229 to Leu [35] or D216 to Asn [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] rendered them less sensitive to DCPIB (EC 50 = 30.7 ± 9.8 μM, 29.6 ± 3.0 % blockade, n = 6, P < 0.05 and EC 50 = 24.6 ± 4.5 μM, 27.1 ± 5.3 % blockade, n = 5, P < 0.05, respectively). Furthermore, DCPIB did not significantly affect the currents given by the double mutant Kir(I229L, D216N) (EC 5 0 = 13.8 ± 2.7 μ M, n = 7, P = 0.88) (Fig. 5c, d ).
A molecular model of DCPIB interactions with a Kir channel reveals sites shared with PIP 2 A docked model of DCPIB on a Kir3.1 chimera structure [18] (see Methods) was compared to a model of PIP 2 interacting with the same channel [16] . As can be appreciated by the direct comparison of the two models, DCPIB and PIP 2 both occupy the same binding pocket, which includes the basic residues K79, K183, and K188 that are thought to bind directly to PIP 2 [16, 32] (Fig. 6a, b) . 
Discussion
The list of ion channels and transporters that depend on interactions with phosphoinositides to maintain their activity continues to grow [11, 12] . Studies on Kir channels in the past two decades have provided the greatest structural insights of how channel PIP 2 interactions might control channel gating. There are only a couple examples of small molecules that enhance or compete with the effects of PIP 2 [20, 36] . Here, we identify a previously well-characterized inhibitor of swelling-activated Cl − currents [2] , DCPIB, as a blocker of Kir channels that show weak apparent affinity to PIP 2 . Our data support a model in which DCPIB is able to compete with PIP 2 to occupy the same binding pocket, provided that the affinity of the channel for PIP 2 is low. Since channels that show the lowest apparent affinity for PIP 2 are the ones most susceptible to modulation by intracellular agents, it may be useful to have a general blocker that acts in pathophysiological situations in which activation of such channels leads to unwanted effects. In the heart for example, constitutive activation of K ACh by unknown mechanisms has been implicated in chronic atrial fibrillation [4] . Whether DCPIB could prove useful in this setting remains to be examined.
The action of DCPIB on Kir channels raises the question whether its effect on I Cl,swell proceeds via a similar mechanism. Addition of 10 μM DiC8 PIP 2 or DiC8 PIP 3 to the patch pipette solution strongly suppresses α 1A-adrenoreceptor and Gq signaling-induced attenuation of I Cl,swell [8, 34] These data suggest I Cl,swell activity critically depends on PIP 2 and PIP 3 binding. Yet, it remains uncertain whether DCPIB acts directly on the I Cl,swell channel protein or on its upstream signaling cascade [3] . The possibility remains that other channels and transporters are susceptible to similar block by DCPIB when their affinity for PIP 2 is low enough because DCPIB seems able to compete effectively with PIP 2 for its protein target.
Recently DCPIB was found to activate TREK potassium channels in cultured astrocytes [17] . Since TREK channels are activated by PIP 2 [14] , it is possible that the DCPIB effect is mediated via an allosteric enhancement of the PIP 2 effect rather than a direct competition with it. DCPIB occupies the same binding pocket within interaction distance from similar residues as PIP 2 . a PIP 2 docked to the Kir3.1 chimera was adapted from the study by Meng and colleagues [25] . b DCPIB was docked to the Kir3.1 chimera (see Methods) and was seen to occupy the same pocket as PIP 2 in (a). Predicted contact residues, which were common to PIP 2 and DCPIB, are indicated in stick depiction. Basic residues are highlighted blue, acidic red, polar green, and non-polar white. The PIP 2 and DCPIB docked ligands are shown in ball-and-stick representation: carbon atoms are cyan, oxygen red, chlorine orange, and phosphorus tan
